Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Samer A. Naffouje

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4973-9597; OpenAlex author ID A5077398822. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2021: 2 papers · 2022: 4 papers · 2023: 1 paper · 2024: 3 papers · 2025: none · 2026: 3 papers

Papers 13

  1. Comparing Palliative Approaches for GOO in Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.1002/jso.70131↗
  2. The Practices of Pancreatic Neck Margin Testing and Their Outcomes after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-026-20092-7↗
  3. ASO Visual Abstract: The Practices of Pancreatic Neck Margin Testing and Their Outcomes After Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1245/s10434-026-20242-x↗
  4. Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis. Last author DOI 10.1007/s00464-024-10783-1↗
  5. Role of minimally invasive surgery in the management of localized pancreatic ductal adenocarcinoma: a review. First author DOI 10.1007/s11701-024-01825-w↗
  6. Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergoing Perioperative Chemotherapy and Resec… Co-author DOI 10.1177/00031348241241738↗
  7. The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma. Last author DOI 10.1016/j.hpb.2023.06.003↗
  8. Surgical approach to pancreaticoduodenectomy for pancreatic adenocarcinoma: uncomplicated ends justify the means. Co-author DOI 10.1007/s00464-021-08845-9↗
  9. Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection. Co-author DOI 10.1007/s11605-021-05130-x↗
  10. Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched St… Co-author DOI 10.1245/s10434-022-12347-w↗
  11. ASO Author Reflections: Minimally Invasive Pancreaticoduodenectomy for Pancreatic Cancer: Are We Maximizing Delivery of Multimodality Therapy? First author DOI 10.1245/s10434-022-12427-x↗
  12. Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study. First author DOI 10.1245/s10434-020-09470-x↗
  13. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population… Co-author DOI 10.1245/s10434-021-09823-0↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fadi S. Dahdaleh · 7 shared papers, 2021–2024 · strength 1.58
  2. Toms Augustin · 6 shared papers, 2023–2026 · strength 1.31
  3. Richard Matthew Walsh · 6 shared papers, 2023–2026 · strength 1.31
  4. Chase J. Wehrle · 5 shared papers, 2024–2026 · strength 1.13
  5. Kathryn A. Stackhouse · 5 shared papers, 2023–2026 · strength 1.10
  6. Jenny H. Chang · 5 shared papers, 2023–2026 · strength 1.07
  7. Kimberly P. Woo · 3 shared papers, 2024–2026 · strength 0.68
  8. Jason W. Denbo · 4 shared papers, 2022–2023 · strength 0.68
  9. Sivesh Kathir Kamarajah · 3 shared papers, 2021–2022 · strength 0.56
  10. George I. Salti · 3 shared papers, 2021–2022 · strength 0.56
  11. Rasha T. Kakati · 1 shared paper, 2024 · strength 0.31
  12. Mokenge Peter Malafa · 2 shared papers, 2022 · strength 0.30
  13. Jason B. Fleming · 2 shared papers, 2022 · strength 0.30
  14. Pamela Joy Hodul · 2 shared papers, 2022 · strength 0.30
  15. Rob Naples · 1 shared paper, 2026 · strength 0.24
  16. Asad Gul Rao · 1 shared paper, 2026 · strength 0.24
  17. Sayf Al-deen Said · 1 shared paper, 2024 · strength 0.21
  18. Breanna C. Perlmutter · 1 shared paper, 2024 · strength 0.21
  19. Steven Alan White · 1 shared paper, 2021 · strength 0.17
  20. Dae Won Kim · 1 shared paper, 2022 · strength 0.15
  21. David T. Pointer · 1 shared paper, 2022 · strength 0.15
  22. Jessica M. Frakes · 1 shared paper, 2022 · strength 0.15
  23. Daniel A. Anaya · 1 shared paper, 2022 · strength 0.15
  24. José M. Pimiento · 1 shared paper, 2022 · strength 0.15
  25. Sarah E. Hoffe · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.